Laurus Labs Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Laurus Labs Limited generated cash of $6,656,900,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,498,300,000 last year. Net change in cash is therefore $932,700,000.
Cash Flow
| 2016 | 1.93B | -3.25B | 1.04B |
|---|---|---|---|
| 2018 | 3.42B | -3.84B | 422.43M |
| 2020 | 3.47B | -2.21B | -1.27B |
| 2021 | 7.33B | -9.40B | 2.54B |
| 2023 | 9.93B | -9.96B | -266.4M |
| 2024 | 6.65B | -8.22B | 2.49B |
LAURUSLABS.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 456.7M | 753.5M | 16.9M | 29.68M | 24.23M | 395.28M |
Operating activities | ||||||
Net income | 1.60B | 11.08B | 13.01B | 2.93B | 2.37B | 1.67B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 3.84B | 3.24B | 2.05B | 1.87B | 1.25B | 921.88M |
Stock-based compensation expense | 109.2M | 74.8M | 28.9M | 36.7M | 33.55M | 22.43M |
| Deferred income tax benefit | 109.2M | 74.8M | 28.9M | 36.7M | 33.55M | 22.43M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -851M | -2.27B | -5.23B | -653.4M | 21.14M | -1.60B |
Inventories | -1.51B | 818.3M | -6.60B | -2.23B | -757.37M | -115.96M |
Accounts payable | 3.34B | -1.68B | 5.59B | 1.12B | 408.47M | 180.39M |
Cash generated by operating activities | 6.65B | 9.93B | 7.33B | 3.47B | 3.42B | 1.93B |
Investing activities | ||||||
Purchases Of Investments | 0 | -223M | -1.6M | -660K | 0 | 0 |
Investments In Property Plant And Equipment | -6.78B | -9.90B | -6.88B | -2.22B | -3.91B | -3.36B |
Acquisitions Net | -716M | -223M | -2.58B | 1.57M | 110K | 5.67M |
Cash generated by investing activities | -8.22B | -9.96B | -9.40B | -2.21B | -3.84B | -3.25B |
Financing activities | ||||||
Common Stock Issued | 25.6M | 74.4M | 73.8M | 26.1M | 2.74M | 2.55M |
Payments for dividends | -861.8M | -1.07B | -750.4M | -385.81M | -158.64M | 0 |
Repurchases of common stock | 0 | 0 | 883.5M | 0 | 0 | 0 |
Repayments of term debt | 5.41B | 2.21B | -957.3M | -32.6M | 1.37B | 2.06B |
Cash used in financing activities | 2.49B | -266.4M | 2.54B | -1.27B | 422.43M | 1.04B |
Net Change In Cash | 932.7M | -296.8M | 467.7M | -12.8M | 5.81M | -267.22M |
Cash at end of period | 1.38B | 456.7M | 484.6M | 16.88M | 30.04M | 128.06M |
| Data source | Data source | Data source | Data source | Data source | Data source |